Viridian Therapeutics, Inc. (VRDN)
19.00
-0.40
(-2.09%)
USD |
NASDAQ |
Oct 05, 16:00
19.00
0.00 (0.00%)
After-Hours: 16:57
Viridian Therapeutics Market Cap : 2.151B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.197B |
| October 01, 2026 | 2.150B |
| September 30, 2026 | 2.332B |
| September 29, 2026 | 2.264B |
| September 28, 2026 | 2.329B |
| September 25, 2026 | 2.318B |
| September 24, 2026 | 2.340B |
| September 23, 2026 | 2.427B |
| September 22, 2026 | 2.505B |
| September 21, 2026 | 2.444B |
| September 18, 2026 | 2.491B |
| September 17, 2026 | 2.483B |
| September 16, 2026 | 2.541B |
| September 15, 2026 | 2.472B |
| September 14, 2026 | 2.514B |
| September 11, 2026 | 2.405B |
| September 10, 2026 | 2.524B |
| September 09, 2026 | 2.574B |
| September 08, 2026 | 2.624B |
| September 04, 2026 | 2.595B |
| September 03, 2026 | 2.600B |
| September 02, 2026 | 2.580B |
| September 01, 2026 | 2.608B |
| August 31, 2026 | 2.623B |
| August 28, 2026 | 2.614B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.704B |
| August 26, 2026 | 2.747B |
| August 25, 2026 | 2.738B |
| August 24, 2026 | 2.720B |
| August 21, 2026 | 2.751B |
| August 20, 2026 | 2.774B |
| August 19, 2026 | 2.808B |
| August 18, 2026 | 2.710B |
| August 17, 2026 | 2.615B |
| August 14, 2026 | 2.500B |
| August 13, 2026 | 2.490B |
| August 12, 2026 | 2.591B |
| August 11, 2026 | 2.601B |
| August 10, 2026 | 2.611B |
| August 07, 2026 | 2.671B |
| August 06, 2026 | 2.549B |
| August 05, 2026 | 2.386B |
| August 04, 2026 | 2.360B |
| August 03, 2026 | 1.978B |
| July 31, 2026 | 1.939B |
| July 30, 2026 | 2.039B |
| July 29, 2026 | 2.037B |
| July 28, 2026 | 1.999B |
| July 27, 2026 | 2.018B |
| July 24, 2026 | 1.974B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.460B |
| Alnylam Pharmaceuticals, Inc. | 29.41B |
| Savara, Inc. | 982.84M |
| Vericel Corp. | 2.104B |
| Biogen, Inc. | 33.01B |
Market Cap Related Metrics
| PS Ratio | 25.79 |
| Price to Book Value | 3.813 |
| Price | 19.00 |
| Earnings Yield | -19.52% |